Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Diseases, Inborn | 14 | 2025 | 453 | 3.200 |
Why?
|
Exome | 37 | 2024 | 1067 | 2.580 |
Why?
|
Sequence Analysis, DNA | 19 | 2019 | 1832 | 2.140 |
Why?
|
Genetic Testing | 17 | 2025 | 1085 | 1.930 |
Why?
|
Prenatal Diagnosis | 10 | 2025 | 627 | 1.570 |
Why?
|
Intellectual Disability | 15 | 2021 | 1076 | 1.220 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2020 | 954 | 1.040 |
Why?
|
Mutation | 23 | 2021 | 6260 | 0.830 |
Why?
|
Phenotype | 28 | 2021 | 4523 | 0.760 |
Why?
|
Genome, Human | 7 | 2019 | 1348 | 0.710 |
Why?
|
Chromosome Disorders | 4 | 2021 | 315 | 0.690 |
Why?
|
Fabry Disease | 6 | 2018 | 18 | 0.670 |
Why?
|
DNA Copy Number Variations | 9 | 2020 | 1021 | 0.640 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2013 | 1061 | 0.640 |
Why?
|
Muscle Hypotonia | 6 | 2019 | 193 | 0.620 |
Why?
|
Alleles | 13 | 2019 | 1704 | 0.620 |
Why?
|
Abnormalities, Multiple | 8 | 2021 | 978 | 0.610 |
Why?
|
Rare Diseases | 4 | 2023 | 204 | 0.600 |
Why?
|
Genetic Counseling | 6 | 2017 | 244 | 0.570 |
Why?
|
Nucleic Acid Hybridization | 4 | 2009 | 397 | 0.560 |
Why?
|
Genetic Variation | 10 | 2019 | 1611 | 0.550 |
Why?
|
Genomics | 9 | 2022 | 1668 | 0.540 |
Why?
|
Mutation, Missense | 9 | 2021 | 925 | 0.520 |
Why?
|
Humans | 113 | 2025 | 133540 | 0.490 |
Why?
|
Child, Preschool | 41 | 2024 | 14762 | 0.470 |
Why?
|
Chromosome Aberrations | 6 | 2019 | 626 | 0.460 |
Why?
|
Exons | 10 | 2020 | 833 | 0.450 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 1871 | 0.440 |
Why?
|
Female | 73 | 2025 | 71524 | 0.440 |
Why?
|
Pedigree | 17 | 2021 | 1692 | 0.440 |
Why?
|
Child | 48 | 2025 | 25711 | 0.440 |
Why?
|
Developmental Disabilities | 6 | 2019 | 733 | 0.420 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2014 | 175 | 0.420 |
Why?
|
Microarray Analysis | 3 | 2019 | 238 | 0.420 |
Why?
|
Gene Rearrangement | 3 | 2011 | 332 | 0.410 |
Why?
|
Sequence Analysis, RNA | 3 | 2025 | 427 | 0.400 |
Why?
|
Fetal Diseases | 3 | 2016 | 461 | 0.400 |
Why?
|
DNA Mutational Analysis | 7 | 2018 | 837 | 0.400 |
Why?
|
Seizures | 5 | 2021 | 892 | 0.400 |
Why?
|
Germ-Line Mutation | 4 | 2025 | 369 | 0.390 |
Why?
|
DNA-Binding Proteins | 8 | 2022 | 2159 | 0.390 |
Why?
|
Male | 67 | 2025 | 65774 | 0.390 |
Why?
|
Genes, Recessive | 4 | 2021 | 194 | 0.390 |
Why?
|
Dystrophin | 2 | 2009 | 45 | 0.380 |
Why?
|
Haploinsufficiency | 7 | 2021 | 274 | 0.370 |
Why?
|
Sequence Deletion | 4 | 2016 | 538 | 0.370 |
Why?
|
INDEL Mutation | 3 | 2020 | 93 | 0.350 |
Why?
|
Physical and Rehabilitation Medicine | 2 | 2022 | 37 | 0.350 |
Why?
|
Epilepsy | 4 | 2021 | 898 | 0.340 |
Why?
|
Enzyme Replacement Therapy | 3 | 2018 | 17 | 0.340 |
Why?
|
Micrognathism | 3 | 2021 | 68 | 0.330 |
Why?
|
Adult | 34 | 2025 | 31933 | 0.330 |
Why?
|
Autistic Disorder | 3 | 2021 | 365 | 0.330 |
Why?
|
Incidental Findings | 3 | 2015 | 129 | 0.320 |
Why?
|
Heterozygote | 11 | 2021 | 716 | 0.310 |
Why?
|
Adolescent | 30 | 2024 | 20514 | 0.310 |
Why?
|
Hand Deformities, Congenital | 2 | 2021 | 95 | 0.310 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2021 | 207 | 0.300 |
Why?
|
Gene Dosage | 6 | 2017 | 456 | 0.300 |
Why?
|
Infant | 24 | 2024 | 13122 | 0.290 |
Why?
|
Congenital Abnormalities | 2 | 2025 | 290 | 0.290 |
Why?
|
Mosaicism | 2 | 2020 | 248 | 0.290 |
Why?
|
Genotyping Techniques | 3 | 2018 | 111 | 0.280 |
Why?
|
Neurodevelopmental Disorders | 3 | 2018 | 529 | 0.280 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2008 | 82 | 0.280 |
Why?
|
alpha-Galactosidase | 6 | 2018 | 20 | 0.280 |
Why?
|
Transcription Factors | 5 | 2025 | 2701 | 0.280 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2019 | 2935 | 0.280 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2025 | 619 | 0.280 |
Why?
|
Homozygote | 6 | 2019 | 560 | 0.270 |
Why?
|
Membrane Proteins | 5 | 2018 | 1603 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 6 | 2024 | 3471 | 0.260 |
Why?
|
Chromosome Deletion | 3 | 2017 | 664 | 0.260 |
Why?
|
Megalencephaly | 2 | 2017 | 58 | 0.260 |
Why?
|
Mucopolysaccharidosis II | 4 | 2011 | 18 | 0.250 |
Why?
|
Craniofacial Abnormalities | 2 | 2019 | 250 | 0.250 |
Why?
|
Urogenital Abnormalities | 2 | 2019 | 160 | 0.250 |
Why?
|
Fibroblasts | 4 | 2024 | 920 | 0.240 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2025 | 23 | 0.230 |
Why?
|
Kidney Diseases | 5 | 2019 | 504 | 0.230 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 694 | 0.230 |
Why?
|
Patient Satisfaction | 2 | 2020 | 504 | 0.220 |
Why?
|
Stillbirth | 1 | 2025 | 103 | 0.220 |
Why?
|
Language Development Disorders | 2 | 2017 | 179 | 0.220 |
Why?
|
Ultrasonography, Prenatal | 3 | 2019 | 982 | 0.220 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2017 | 384 | 0.220 |
Why?
|
Loss of Function Mutation | 3 | 2021 | 159 | 0.210 |
Why?
|
Cell Transdifferentiation | 1 | 2024 | 67 | 0.210 |
Why?
|
Heart Defects, Congenital | 5 | 2018 | 1879 | 0.210 |
Why?
|
Meningioma | 1 | 2025 | 140 | 0.200 |
Why?
|
Young Adult | 14 | 2021 | 9899 | 0.200 |
Why?
|
Genetic Association Studies | 5 | 2019 | 843 | 0.200 |
Why?
|
Syndrome | 8 | 2018 | 1148 | 0.200 |
Why?
|
Fetus | 2 | 2018 | 600 | 0.200 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2025 | 233 | 0.200 |
Why?
|
Pregnancy | 8 | 2025 | 7509 | 0.200 |
Why?
|
Meningeal Neoplasms | 1 | 2025 | 215 | 0.200 |
Why?
|
Facies | 3 | 2017 | 154 | 0.190 |
Why?
|
Microcephaly | 3 | 2016 | 348 | 0.190 |
Why?
|
Computational Biology | 3 | 2017 | 886 | 0.190 |
Why?
|
Point Mutation | 3 | 2016 | 359 | 0.190 |
Why?
|
De Lange Syndrome | 2 | 2019 | 45 | 0.190 |
Why?
|
Comparative Genomic Hybridization | 4 | 2013 | 577 | 0.190 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 65 | 0.190 |
Why?
|
Gene Duplication | 3 | 2008 | 371 | 0.190 |
Why?
|
Nervous System Diseases | 3 | 2024 | 405 | 0.190 |
Why?
|
Musculoskeletal Abnormalities | 2 | 2019 | 71 | 0.180 |
Why?
|
Cytokine Receptor gp130 | 1 | 2021 | 13 | 0.180 |
Why?
|
Myoclonic Epilepsies, Progressive | 1 | 2021 | 13 | 0.180 |
Why?
|
Prolotherapy | 1 | 2021 | 1 | 0.180 |
Why?
|
Uniparental Disomy | 1 | 2021 | 49 | 0.180 |
Why?
|
Rotator Cuff Injuries | 1 | 2021 | 9 | 0.180 |
Why?
|
Job Syndrome | 1 | 2021 | 17 | 0.180 |
Why?
|
Shoulder Pain | 1 | 2021 | 18 | 0.180 |
Why?
|
Calcineurin | 1 | 2021 | 101 | 0.170 |
Why?
|
Platelet-Rich Plasma | 1 | 2021 | 18 | 0.170 |
Why?
|
Genetic Carrier Screening | 2 | 2020 | 72 | 0.170 |
Why?
|
Trans-Activators | 1 | 2025 | 827 | 0.170 |
Why?
|
Infant, Newborn | 11 | 2018 | 8571 | 0.170 |
Why?
|
Spectrin | 1 | 2021 | 62 | 0.170 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 117 | 0.170 |
Why?
|
Potassium Channels | 1 | 2021 | 165 | 0.170 |
Why?
|
Metalloendopeptidases | 2 | 2017 | 101 | 0.160 |
Why?
|
Autopsy | 2 | 2016 | 119 | 0.160 |
Why?
|
Thanatophoric Dysplasia | 1 | 2019 | 6 | 0.160 |
Why?
|
Actins | 2 | 2021 | 352 | 0.160 |
Why?
|
Dynamins | 1 | 2019 | 43 | 0.160 |
Why?
|
Osteoarthritis | 1 | 2021 | 103 | 0.160 |
Why?
|
Nuchal Translucency Measurement | 1 | 2019 | 18 | 0.160 |
Why?
|
Lymphangioma, Cystic | 1 | 2019 | 18 | 0.160 |
Why?
|
Iduronate Sulfatase | 2 | 2011 | 20 | 0.160 |
Why?
|
Base Sequence | 5 | 2022 | 3168 | 0.160 |
Why?
|
Adenosine Triphosphatases | 2 | 2017 | 200 | 0.150 |
Why?
|
Neurocutaneous Syndromes | 1 | 2019 | 16 | 0.150 |
Why?
|
Achondroplasia | 1 | 2019 | 24 | 0.150 |
Why?
|
Acrocephalosyndactylia | 1 | 2019 | 22 | 0.150 |
Why?
|
Fragile X Syndrome | 1 | 2020 | 155 | 0.150 |
Why?
|
Chromosomal Instability | 1 | 2019 | 63 | 0.150 |
Why?
|
Biological Variation, Population | 1 | 2018 | 25 | 0.150 |
Why?
|
Hydrops Fetalis | 1 | 2019 | 77 | 0.150 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.150 |
Why?
|
Collagen Type I | 1 | 2019 | 130 | 0.150 |
Why?
|
Osteochondrodysplasias | 1 | 2019 | 68 | 0.150 |
Why?
|
Proline-Rich Protein Domains | 1 | 2018 | 2 | 0.150 |
Why?
|
Genetics, Medical | 2 | 2016 | 122 | 0.150 |
Why?
|
Carrier Proteins | 3 | 2021 | 1061 | 0.150 |
Why?
|
Cell-Free Nucleic Acids | 1 | 2019 | 57 | 0.150 |
Why?
|
Mitochondrial Proteins | 2 | 2017 | 243 | 0.150 |
Why?
|
Endocytosis | 1 | 2018 | 131 | 0.150 |
Why?
|
Iris Diseases | 1 | 2018 | 15 | 0.150 |
Why?
|
Dwarfism | 2 | 2016 | 102 | 0.150 |
Why?
|
Smith-Magenis Syndrome | 1 | 2019 | 105 | 0.150 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 230 | 0.140 |
Why?
|
Confidentiality | 2 | 2016 | 107 | 0.140 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2018 | 125 | 0.140 |
Why?
|
Ultrasonography | 2 | 2022 | 993 | 0.140 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2017 | 7 | 0.140 |
Why?
|
Mitochondrial Diseases | 1 | 2019 | 139 | 0.140 |
Why?
|
Chorionic Villi Sampling | 2 | 2015 | 46 | 0.140 |
Why?
|
Insurance, Health | 1 | 2018 | 144 | 0.140 |
Why?
|
Chromosome Banding | 2 | 2008 | 140 | 0.140 |
Why?
|
Insurance Coverage | 1 | 2018 | 124 | 0.140 |
Why?
|
Eye Abnormalities | 1 | 2018 | 105 | 0.140 |
Why?
|
Survival of Motor Neuron 1 Protein | 1 | 2017 | 20 | 0.140 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 42 | 0.130 |
Why?
|
Pyrroline Carboxylate Reductases | 1 | 2016 | 6 | 0.130 |
Why?
|
Students, Medical | 1 | 2022 | 365 | 0.130 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2016 | 19 | 0.130 |
Why?
|
Bone Diseases, Developmental | 1 | 2017 | 59 | 0.130 |
Why?
|
Amino Acid Sequence | 6 | 2016 | 2783 | 0.130 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2017 | 45 | 0.130 |
Why?
|
Situs Inversus | 1 | 2016 | 26 | 0.130 |
Why?
|
Software | 2 | 2019 | 735 | 0.130 |
Why?
|
Tumor Protein p73 | 1 | 2016 | 31 | 0.130 |
Why?
|
Endopeptidases | 1 | 2017 | 118 | 0.130 |
Why?
|
Genes, Dominant | 2 | 2015 | 254 | 0.130 |
Why?
|
p21-Activated Kinases | 1 | 2017 | 58 | 0.130 |
Why?
|
Glycoproteins | 2 | 2011 | 380 | 0.130 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2016 | 39 | 0.130 |
Why?
|
Osteogenesis Imperfecta | 1 | 2019 | 167 | 0.130 |
Why?
|
Betacoronavirus | 1 | 2020 | 309 | 0.130 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 100 | 0.130 |
Why?
|
Sudden Infant Death | 1 | 2016 | 36 | 0.130 |
Why?
|
Bone and Bones | 1 | 2019 | 308 | 0.130 |
Why?
|
Radiculopathy | 1 | 2016 | 6 | 0.130 |
Why?
|
NF-kappa B | 1 | 2019 | 482 | 0.130 |
Why?
|
Psychomotor Disorders | 1 | 2016 | 29 | 0.130 |
Why?
|
Founder Effect | 1 | 2016 | 34 | 0.130 |
Why?
|
Curriculum | 1 | 2022 | 776 | 0.130 |
Why?
|
Cystic Fibrosis | 2 | 2012 | 262 | 0.130 |
Why?
|
Brain Diseases | 1 | 2019 | 310 | 0.130 |
Why?
|
Feeding and Eating Disorders | 1 | 2017 | 76 | 0.130 |
Why?
|
Limb Deformities, Congenital | 1 | 2017 | 110 | 0.130 |
Why?
|
Death, Sudden | 1 | 2016 | 50 | 0.130 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 50 | 0.130 |
Why?
|
Geminin | 1 | 2015 | 7 | 0.130 |
Why?
|
Failure to Thrive | 1 | 2016 | 91 | 0.130 |
Why?
|
Polyhydramnios | 1 | 2016 | 56 | 0.130 |
Why?
|
Ethics, Medical | 2 | 2016 | 403 | 0.120 |
Why?
|
DNA Helicases | 2 | 2017 | 251 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2025 | 17436 | 0.120 |
Why?
|
Patella | 1 | 2015 | 26 | 0.120 |
Why?
|
Transposases | 1 | 2016 | 45 | 0.120 |
Why?
|
Physicians | 2 | 2020 | 630 | 0.120 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2016 | 82 | 0.120 |
Why?
|
Neurons | 2 | 2024 | 2034 | 0.120 |
Why?
|
Rhabdomyolysis | 1 | 2016 | 37 | 0.120 |
Why?
|
Functional Laterality | 1 | 2016 | 197 | 0.120 |
Why?
|
Molecular Sequence Data | 6 | 2016 | 3968 | 0.120 |
Why?
|
Leukoencephalopathies | 1 | 2016 | 61 | 0.120 |
Why?
|
DNA Damage | 1 | 2019 | 542 | 0.120 |
Why?
|
Neoplasms | 2 | 2024 | 3007 | 0.120 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 113 | 0.120 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2016 | 58 | 0.120 |
Why?
|
Genetic Linkage | 1 | 2017 | 480 | 0.120 |
Why?
|
Congenital Microtia | 1 | 2015 | 24 | 0.120 |
Why?
|
Vesicular Transport Proteins | 1 | 2016 | 121 | 0.120 |
Why?
|
Muscle Weakness | 1 | 2016 | 95 | 0.120 |
Why?
|
Mitochondria | 2 | 2019 | 737 | 0.120 |
Why?
|
Karyotyping | 2 | 2012 | 324 | 0.120 |
Why?
|
Coronavirus Infections | 1 | 2020 | 388 | 0.110 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 399 | 0.110 |
Why?
|
Disease | 1 | 2016 | 134 | 0.110 |
Why?
|
Cardiomyopathies | 2 | 2016 | 528 | 0.110 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2012 | 47 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 1 | 2016 | 248 | 0.110 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2016 | 214 | 0.110 |
Why?
|
Amniotic Fluid | 1 | 2015 | 152 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 2 | 2016 | 471 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 123 | 0.110 |
Why?
|
Growth Disorders | 1 | 2015 | 221 | 0.110 |
Why?
|
RNA Splicing | 3 | 2025 | 250 | 0.110 |
Why?
|
Telemedicine | 1 | 2020 | 498 | 0.110 |
Why?
|
CHARGE Syndrome | 1 | 2013 | 8 | 0.110 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 485 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 509 | 0.110 |
Why?
|
Genes, X-Linked | 1 | 2013 | 63 | 0.110 |
Why?
|
Gaucher Disease | 1 | 2013 | 12 | 0.100 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 78 | 0.100 |
Why?
|
Glucosylceramidase | 1 | 2013 | 27 | 0.100 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 2307 | 0.100 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2012 | 19 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 392 | 0.100 |
Why?
|
Muscle Spasticity | 1 | 2013 | 78 | 0.100 |
Why?
|
Inheritance Patterns | 3 | 2018 | 131 | 0.100 |
Why?
|
Introns | 2 | 2016 | 313 | 0.100 |
Why?
|
Autophagy | 1 | 2016 | 420 | 0.100 |
Why?
|
Informed Consent | 1 | 2015 | 345 | 0.100 |
Why?
|
Genes, Duplicate | 1 | 2012 | 16 | 0.100 |
Why?
|
Munc18 Proteins | 1 | 2012 | 20 | 0.100 |
Why?
|
Pandemics | 1 | 2020 | 1192 | 0.100 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 456 | 0.100 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2012 | 73 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 1160 | 0.090 |
Why?
|
Autism Spectrum Disorder | 1 | 2017 | 421 | 0.090 |
Why?
|
DNA Replication | 1 | 2013 | 362 | 0.090 |
Why?
|
Internship and Residency | 1 | 2022 | 1251 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2025 | 3063 | 0.090 |
Why?
|
Alu Elements | 1 | 2011 | 66 | 0.090 |
Why?
|
Gene Deletion | 4 | 2017 | 809 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2014 | 571 | 0.090 |
Why?
|
Spinocerebellar Ataxias | 1 | 2013 | 254 | 0.090 |
Why?
|
Heart Diseases | 2 | 2006 | 527 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 1967 | 0.080 |
Why?
|
Recombination, Genetic | 1 | 2011 | 452 | 0.080 |
Why?
|
Animals | 10 | 2021 | 36266 | 0.080 |
Why?
|
Organ Specificity | 2 | 2007 | 444 | 0.080 |
Why?
|
Methods | 1 | 2008 | 144 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 2165 | 0.070 |
Why?
|
Lysosomal Storage Diseases | 1 | 2008 | 37 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2008 | 145 | 0.070 |
Why?
|
Noonan Syndrome | 1 | 2008 | 31 | 0.070 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2008 | 95 | 0.070 |
Why?
|
Genetic Heterogeneity | 2 | 2018 | 141 | 0.070 |
Why?
|
Muscles | 2 | 2019 | 307 | 0.070 |
Why?
|
Zebrafish | 2 | 2021 | 417 | 0.070 |
Why?
|
United States | 6 | 2022 | 11656 | 0.070 |
Why?
|
ATPases Associated with Diverse Cellular Activities | 2 | 2017 | 78 | 0.070 |
Why?
|
Databases, Genetic | 2 | 2019 | 501 | 0.070 |
Why?
|
Nuclear Proteins | 3 | 2018 | 1334 | 0.070 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2006 | 12 | 0.070 |
Why?
|
Kidney | 3 | 2019 | 1404 | 0.070 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2006 | 99 | 0.060 |
Why?
|
Hearing Loss | 1 | 2008 | 213 | 0.060 |
Why?
|
Gastrointestinal Diseases | 2 | 2008 | 360 | 0.060 |
Why?
|
Isoenzymes | 1 | 2006 | 232 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2016 | 676 | 0.060 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 412 | 0.060 |
Why?
|
Registries | 2 | 2008 | 1559 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2004 | 69 | 0.060 |
Why?
|
Middle Aged | 9 | 2020 | 29347 | 0.060 |
Why?
|
Caenorhabditis elegans | 2 | 2016 | 240 | 0.050 |
Why?
|
Gene Expression | 2 | 2021 | 1612 | 0.050 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2006 | 310 | 0.050 |
Why?
|
Genotype | 3 | 2019 | 2805 | 0.050 |
Why?
|
Disease Management | 2 | 2018 | 559 | 0.050 |
Why?
|
Cell Cycle | 2 | 2017 | 625 | 0.050 |
Why?
|
Germ Cells | 1 | 2024 | 202 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2004 | 368 | 0.050 |
Why?
|
Texas | 2 | 2024 | 3681 | 0.050 |
Why?
|
Lung Diseases | 1 | 2006 | 399 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 40 | 0.050 |
Why?
|
MutL Protein Homolog 1 | 1 | 2022 | 54 | 0.050 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 48 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2017 | 805 | 0.050 |
Why?
|
Face | 2 | 2017 | 183 | 0.050 |
Why?
|
Laboratories | 1 | 2023 | 89 | 0.050 |
Why?
|
Homologous Recombination | 1 | 2022 | 100 | 0.050 |
Why?
|
Electroencephalography | 2 | 2021 | 914 | 0.050 |
Why?
|
Musculoskeletal System | 1 | 2022 | 20 | 0.050 |
Why?
|
Pilot Projects | 2 | 2017 | 1488 | 0.050 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 75 | 0.050 |
Why?
|
Decision Making | 1 | 2006 | 695 | 0.050 |
Why?
|
Phosphorylation | 2 | 2017 | 1698 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 6654 | 0.040 |
Why?
|
Choice Behavior | 1 | 2022 | 137 | 0.040 |
Why?
|
Problem Behavior | 1 | 2021 | 41 | 0.040 |
Why?
|
Career Choice | 1 | 2022 | 160 | 0.040 |
Why?
|
Mice | 4 | 2019 | 18808 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 3839 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2019 | 3956 | 0.040 |
Why?
|
Nephrons | 1 | 2019 | 21 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2021 | 13001 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2019 | 8 | 0.040 |
Why?
|
RNA Splice Sites | 1 | 2019 | 98 | 0.040 |
Why?
|
Aged | 5 | 2020 | 21701 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 1331 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2019 | 24 | 0.040 |
Why?
|
Xenopus laevis | 1 | 2019 | 128 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 77 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2023 | 287 | 0.040 |
Why?
|
Peroxisomes | 1 | 2019 | 42 | 0.040 |
Why?
|
Microfilament Proteins | 1 | 2021 | 289 | 0.040 |
Why?
|
Transferrin | 1 | 2018 | 50 | 0.040 |
Why?
|
Urinary Tract | 1 | 2019 | 64 | 0.040 |
Why?
|
Endosomes | 1 | 2018 | 68 | 0.040 |
Why?
|
Outpatients | 1 | 2020 | 267 | 0.040 |
Why?
|
Antigens, Nuclear | 1 | 2018 | 57 | 0.040 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 170 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2019 | 156 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 141 | 0.040 |
Why?
|
Drug Resistant Epilepsy | 1 | 2021 | 224 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 5177 | 0.040 |
Why?
|
Myelin Sheath | 1 | 2018 | 126 | 0.040 |
Why?
|
Infant Care | 1 | 2017 | 47 | 0.040 |
Why?
|
Mass Screening | 1 | 2003 | 832 | 0.030 |
Why?
|
Survival of Motor Neuron 2 Protein | 1 | 2017 | 13 | 0.030 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2017 | 32 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2019 | 4742 | 0.030 |
Why?
|
Transcriptome | 1 | 2024 | 1121 | 0.030 |
Why?
|
Philadelphia Chromosome | 1 | 2017 | 43 | 0.030 |
Why?
|
Growth Charts | 1 | 2016 | 15 | 0.030 |
Why?
|
Oryzias | 1 | 2016 | 9 | 0.030 |
Why?
|
PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.030 |
Why?
|
Codon | 1 | 2016 | 108 | 0.030 |
Why?
|
Consent Forms | 1 | 2016 | 22 | 0.030 |
Why?
|
Coroners and Medical Examiners | 1 | 2016 | 15 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2017 | 123 | 0.030 |
Why?
|
Gene Frequency | 1 | 2018 | 778 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2003 | 875 | 0.030 |
Why?
|
Models, Animal | 1 | 2018 | 480 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 324 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2016 | 78 | 0.030 |
Why?
|
Everolimus | 1 | 2016 | 50 | 0.030 |
Why?
|
Injections, Epidural | 1 | 2016 | 6 | 0.030 |
Why?
|
Age of Onset | 2 | 2008 | 636 | 0.030 |
Why?
|
Diagnosis | 1 | 2016 | 30 | 0.030 |
Why?
|
Betamethasone | 1 | 2016 | 14 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 2017 | 122 | 0.030 |
Why?
|
Triamcinolone | 1 | 2016 | 14 | 0.030 |
Why?
|
Diseases in Twins | 1 | 2017 | 99 | 0.030 |
Why?
|
Signal Transduction | 2 | 2021 | 4879 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2017 | 172 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2013 | 1437 | 0.030 |
Why?
|
Fathers | 1 | 2017 | 73 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2016 | 201 | 0.030 |
Why?
|
Optic Atrophy | 1 | 2016 | 47 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 215 | 0.030 |
Why?
|
Arabs | 1 | 2016 | 29 | 0.030 |
Why?
|
Heterotaxy Syndrome | 1 | 2016 | 61 | 0.030 |
Why?
|
Family Health | 1 | 2017 | 267 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2018 | 362 | 0.030 |
Why?
|
Skin | 1 | 2019 | 551 | 0.030 |
Why?
|
Cysteine | 1 | 2016 | 142 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2017 | 386 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 650 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2017 | 269 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2003 | 911 | 0.030 |
Why?
|
Golgi Apparatus | 1 | 2016 | 96 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2015 | 64 | 0.030 |
Why?
|
Cell Death | 1 | 2016 | 249 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 172 | 0.030 |
Why?
|
Amino Acids | 1 | 2018 | 688 | 0.030 |
Why?
|
Interview, Psychological | 1 | 2015 | 102 | 0.030 |
Why?
|
Disclosure | 1 | 2016 | 154 | 0.030 |
Why?
|
Family | 1 | 2018 | 589 | 0.030 |
Why?
|
Physical Examination | 1 | 2016 | 164 | 0.030 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2016 | 129 | 0.030 |
Why?
|
Health Care Costs | 1 | 2018 | 403 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2016 | 196 | 0.030 |
Why?
|
Cytokines | 1 | 2021 | 1395 | 0.030 |
Why?
|
Proteolysis | 1 | 2015 | 190 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 611 | 0.030 |
Why?
|
Sirolimus | 1 | 2016 | 255 | 0.030 |
Why?
|
Patients | 1 | 2015 | 127 | 0.030 |
Why?
|
Brain | 2 | 2016 | 3211 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2015 | 633 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 382 | 0.030 |
Why?
|
National Human Genome Research Institute (U.S.) | 1 | 2013 | 19 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 456 | 0.030 |
Why?
|
Medical Oncology | 1 | 2015 | 242 | 0.030 |
Why?
|
Drosophila | 1 | 2018 | 824 | 0.030 |
Why?
|
Mothers | 1 | 2017 | 369 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 590 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2016 | 257 | 0.030 |
Why?
|
Axons | 1 | 2016 | 395 | 0.030 |
Why?
|
Parents | 1 | 2020 | 1060 | 0.030 |
Why?
|
Drug Substitution | 1 | 2013 | 22 | 0.030 |
Why?
|
Protein Binding | 1 | 2017 | 1831 | 0.030 |
Why?
|
Karyotype | 1 | 2012 | 32 | 0.030 |
Why?
|
Models, Molecular | 1 | 2016 | 1128 | 0.030 |
Why?
|
Metabolomics | 1 | 2016 | 455 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2019 | 3161 | 0.030 |
Why?
|
Platelet Count | 1 | 2013 | 143 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2013 | 254 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 2012 | 137 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2022 | 1400 | 0.020 |
Why?
|
Maternal Age | 1 | 2012 | 139 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 149 | 0.020 |
Why?
|
Patient Preference | 1 | 2013 | 135 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 683 | 0.020 |
Why?
|
Length of Stay | 1 | 2017 | 1374 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 1124 | 0.020 |
Why?
|
Cell Line | 1 | 2017 | 2833 | 0.020 |
Why?
|
Brain Waves | 1 | 2012 | 52 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2022 | 3992 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2016 | 867 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 323 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 912 | 0.020 |
Why?
|
Segmental Duplications, Genomic | 1 | 2011 | 81 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 755 | 0.020 |
Why?
|
Glycosaminoglycans | 1 | 2011 | 35 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2016 | 837 | 0.020 |
Why?
|
Protein Conformation | 1 | 2012 | 871 | 0.020 |
Why?
|
Transfection | 1 | 2012 | 1085 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 1130 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 291 | 0.020 |
Why?
|
Down Syndrome | 1 | 2012 | 230 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 468 | 0.020 |
Why?
|
Genetic Loci | 1 | 2011 | 365 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2019 | 5491 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 572 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2017 | 2537 | 0.020 |
Why?
|
Sweating | 1 | 2008 | 7 | 0.020 |
Why?
|
Amniocentesis | 1 | 2009 | 77 | 0.020 |
Why?
|
Body Temperature Regulation | 1 | 2008 | 50 | 0.020 |
Why?
|
Chromosome Breakage | 1 | 2008 | 167 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2008 | 22 | 0.020 |
Why?
|
NADPH Oxidases | 1 | 2008 | 114 | 0.020 |
Why?
|
Neuralgia | 1 | 2008 | 54 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2008 | 114 | 0.020 |
Why?
|
Quality of Life | 2 | 2008 | 2130 | 0.020 |
Why?
|
Awards and Prizes | 1 | 2008 | 71 | 0.020 |
Why?
|
Body Height | 1 | 2008 | 231 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 126 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2009 | 373 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 1848 | 0.020 |
Why?
|
Drug Tolerance | 1 | 2006 | 40 | 0.020 |
Why?
|
Vital Capacity | 1 | 2006 | 79 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1323 | 0.020 |
Why?
|
History, 20th Century | 1 | 2008 | 397 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 161 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2007 | 335 | 0.020 |
Why?
|
Safety | 1 | 2006 | 224 | 0.020 |
Why?
|
Sequence Analysis | 1 | 2004 | 54 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2007 | 536 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 1034 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 1250 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2007 | 1486 | 0.010 |
Why?
|
Liver | 1 | 2011 | 1850 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2006 | 1669 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 895 | 0.010 |
Why?
|
DNA | 1 | 2005 | 1665 | 0.010 |
Why?
|
Incidence | 1 | 2003 | 3386 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 2077 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2003 | 7202 | 0.010 |
Why?
|